# Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients

> **NCT04679272** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 2000 (actual)

## Conditions studied

- Covid19
- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04679272
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-02-01
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04679272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04679272, "Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04679272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*